Skip to main content
Download PDF

The association between patent foramen ovale and unexplained syncope in pediatric patients

Italian Journal of Pediatrics volume 50, Article number: 2 (2024) Cite this article

Abstract

Background

Patent foramen ovale (PFO) is associated with transient ischemia attack (TIA) or stroke, paradoxical embolism, and migraines. PFO closure decreases the recurrent incidence of cerebral ischemic events and reduces the incidence of syncope in adults. However, whether PFO is associated with syncope in pediatric patients has not been investigated.

Methods

1001 pediatric patients (aged 4 to 17 years, mean age 10.31 ± 2.61 years, 519 males) who complained of unexplained syncope, palpitation, headache, dizziness and chest pain and were hospitalized in the Syncope Ward, The Second Xiangya Hospital, Central South University between January 2013 and April 2022 were recruited. Children with definite etiology of syncope, neurological, cardiogenic, psychological and other system diseases were excluded. PFO was measured by transthoracic echocardiography and right-heart contrast echocardiography was performed to identify the presence of right-to-left shunting. The demographic data and medical records were retrospectively reviewed and analyzed.

Results

276 cases were included in the simple syncope group, 379 cases in the headache/dizziness group, 265 cases in the chest pain group, and 81 cases in the palpitation group. The incidence of PFO between the four groups was insignificant (4.71%, 4.74%, 4.15%, 6.17%, respectively, P = 0.903). Multivariate Logistic regression demonstrated that PFO is not associated with the increased risk of syncope (P = 0.081).

Conclusion

PFO may not increase the risk of syncope in pediatric patients. Further study may include a large and multicenter sample to investigate the association between PFO and unexplained syncope.

Background

Syncope is frequent in children and accounts for 1% of emergencies [1]. Though most patients have benign causes of syncope, the recurrent onset of syncope may affect children’s life quality and bring syncope-associated injury [2]. It is important to identify the risk factors of syncope for effective preventive measures to reduce syncopal attacks.

Foramen ovale is an intracardiac structure for fetal circulation. Most foramina ovalia functionally close within a few days to several months after birth due to pulmonary circulatory blood flow and left atrial pressure increase. Patent foramen ovale (PFO) is a remnant of fetal foramen ovale with an overall incidence of 27.3% [3]. PFO is associated with transient ischemia attack (TIA) or stroke, paradoxical embolism, and migraine in adults [4], and PFO closure may reduce the risk of PFO-associated stroke in patients younger than 60 years with an embolic-appearing stroke [5, 6]. Besides, PFO closure also decreases the incidences of platypnea-orthodeoxia, fainting episodes, syncope, and migraine headaches [7]. PFO is more common in children, and the incidence is 34.3% during the first three decades of life [3]. Whether PFO is associated with syncope in pediatric patients has not been investigated yet. In this study, we aim to investigate the association between PFO and syncope in children.

Study population and methods

Study population and data collection

Patients who complained of unexplained syncope, palpitation, headache/dizziness, and chest pain were hospitalized in the Syncope Ward, The Second Xiangya Hospital, Central South University between January 2013 and April 2022. The demographic data and medical records were retrospectively reviewed by two researchers. Neurological, cardiogenic, psychological, and other system diseases were excluded after an initial evaluation consisting of history, physical examination, baseline laboratory testing, electrocardiogram (ECG), Holter ECG, echocardiography, chest X-ray, electroencephalogram, and cranial CT or MRI. Head-up tilt test was performed according to the previous study [8] to exclude neurally-mediated syncope. Patients were divided into four groups according to their symptoms: simple syncope group, headache/dizziness group, chest pain group and palpitation group. The exclusion and inclusion process are shown as Fig. 1.

Fig. 1
figure 1

Flow chart of the study population exclusion and inclusion. (Note: HUTT, head-up tilt test)

Full size image

Patent foramen ovale measurement

PFO was monitored by transthoracic echocardiography, and the standard echocardiographic protocol was performed according to the American Society of Echocardiography [9]. Right-heart contrast echocardiography was performed to identify the presence of right-to-left shunting, by using agitated saline (80%) combined with air (10%) and the patient’s own blood (10%) when the patient was at rest or performing a Valsalva maneuver. Microbubbles were detected in the left atrium during 3 to 5 cardiac cycles [10, 11].

Statistical analysis

Statistical analysis was performed by SPSS 24.0 (IBM Corp., Armonk, NY, United States). Continuous variables for data following normal distribution were described as mean ± SD and analyzed by one-way ANOVA with polynomial contrasts and post hoc LSD among groups. Categorical data were described by frequencies and percentages and analyzed using x2 test or Fisher’s exact test. Univariate analysis and multiple Logistic regression were utilized to analyze the association between unexplained syncope and related factors. P-value < 0.05 was considered to be a statistically significant difference.

Results

A total of 1001 patients, aged 4 to 17 years (mean age 10.31 ± 2.61 years) with 519 males (51.85%), were recruited in the study. As shown in Tables 1, 276 cases [mean age 10.60 ± 2.75 years, 138 males (50.00%)] were included in the simple syncope group, 379 cases [mean age 10.25 ± 2.38 years, 200 males (52.77%)] in the headache/dizziness group, 265 cases [mean age 10.32 ± 2.60 years, 143 males (53.96%)] in the chest pain group, and 81 cases [mean age 9.61 ± 3.08 years, 38 males (46.91%)] in the palpitation group. Patients in the palpitation group were younger than those patients in the simple syncope group, headache/dizziness group, and palpitation group (all P < 0.05). However, there were no significant differences in sex ratio, height, body weight, systolic blood pressure, diastolic blood pressure, heart rate, ejection fraction, and fractional shortening between the four groups (all P > 0.05). 13 (4.71%) patients in the simple syncope group, 18 (4.74%) patients in the headache/dizziness group, 11 (4.15%) children in the chest pain group, and 5 (6.17%) children in the palpitation group have PFO. There was no significant difference in the proportion of PFO between these groups (P = 0.903). 4 patients in the headache/dizziness group presented a positive bubble study, but no patient in the simple syncope group had a positive bubble study.

Table 1 The demographic data and clinical characteristics in children with unexplained syncope, headache/dizziness, chest pain and palpitation
Full size table

Univariate analysis for unexplained syncope was performed. As shown in Table 2, we found a positive association between age and unexplained syncope. With one-year increase in age, the risk of syncope was raised by 6.0% (OR = 1.060, 95%CI: 1.004–1.119, P = 0.036). PFO was not associated with unexplained syncope in children (P = 0.989). Multivariate Logistic regression demonstrated that PFO was not the independent factor of syncope (P = 0.081) (Table 3). These results suggested that the incidence of syncope is not associated with PFO in children.

Table 2 Univariate analysis for unexplained syncope in children
Full size table
Table 3 Multivariate Logistic regression analysis between unexplained syncope and related factors in children
Full size table

Discussion

In this study, we assess the relationship between syncope and PFO in pediatric patients with unexplained syncope, headache, dizziness, palpitation, and chest pain. The results demonstrated that the incidence of PFO had no significant differences in children with or without syncope. Unlike adults, PFO did not increase the risk of syncope in pediatric patients.

Previous studies suggested that PFO is associated with stroke in adults. 40–50% of patients who underwent a cryptogenic stroke have PFO [12]. Half of the patients with a history of PFO-related stroke also had symptoms of syncope and palpitation [13]. A study demonstrated that the prevalence of PFO in patients with explained syncope was 75.4% [14], while it was 20–25% in the general population [15]. Based on the above results, it is concluded that PFO is highly correlated with unexplained syncope in adults, especially during exercise or an increase in abdominal pressure.

The main mechanism of PFO-related syncope may be associated with paradoxical embolism. First, when laughing, coughing, or doing other activities, the pressure of the right atrium increases transiently, which will push open the primary septum to the left atrium and cause right-to-left shunting. Vasoactive substances and thrombi from the venous system enter the intracranial arterial system through right-to-left shunting, which results in arterial spasms and transient cerebral ischemia, inducing syncope [16]. Second, the emboli caused by the repeated opening of the foramen ovale or lower limb veins fall off and enter the left atrium. Then the emboli are pushed into the systemic circulation from the left atrium, leading to arterial embolism, which may lead to stroke, myocardial infarction, and syncope [17, 18]. Third, venous blood shunted from the right atrium to the left heart system makes the cerebral blood supply become mixed arteriovenous blood supplies, causing transient cerebral ischemia and hypoxia, resulting in syncope [19].

The results of our study demonstrated that PFO was not associated with syncope in pediatric patients, which contradicts the results in adults. In our study, 4 patients in the headache/dizziness group presented a positive bubble study, suggesting the presence of right-to-left shunting. However, the 4 patients did not experience syncope. It is believed that the thrombi, air thrombi, and vasoactive substances of the venous system in children are fewer compared with adults. Fewer emboli from the venous system enter systemic circulation through PFO though the existence of right-to-left shunting. Besides, the diameter of PFO is clinically significant and positively related to the severity of diseases. When the diameter is less than 4 mm, the blood diversion is slight, and the probability of paradoxical embolism is lower [10]. On the other hand, no patient in the simple syncope group presented a positive bubble study, suggesting no existence of right-to-left shunting in these patients. The results indicated that syncope is unrelated to PFO in these children.

There are several limitations in the study. First, this was a retrospective and single-center study, which resulted in bias and underestimation of some important factors. Patients included in the study complained of unexplained syncope, palpitation, headache, dizziness, and chest pain, but healthy individuals with PFO were not included. The incidence of PFO in our study was lower than that of the general population. Besides, the sample size of patients with PFO and the proportion of patients with positive bubble studies was small. We believed that because it is difficult for children to perform the Valsalva maneuver correctly.

Conclusion

PFO may not increase the risk of syncope in pediatric patients. Further study may include a large and multicenter sample to investigate the association between PFO and unexplained syncope.

Data availability

The original contributions presented in the study are included in the article/supplementary material, further inquiries can be directed to the corresponding author.

Abbreviations

PFO:

Patent foramen ovale

ECG:

Electrocardiogram

References

  1. Chen L, Wang C, Wang H, Tian H, Tang C, Jin H, et al. Underlying Diseases in syncope of children in China. Med Sci Monit. 2011;17(6):PH49–53. https://doi.org/10.12659/msm.881795.

    Article  PubMed  Google Scholar 

  2. Wang C, Li Y, Liao Y, Tian H, Huang M, Dong X et al. 2018 Chinese Pediatric Cardiology Society (CPCS) guideline for diagnosis and treatment of syncope in children and adolescents. Sci Bull (Beijing) 2018,63(23):1558–64. https://doi.org/10.1016/j.scib.2018.09.019.

  3. Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc. 1984;59(1):17–20. https://doi.org/10.1016/s0025-6196(12)60336-x.

    Article  CAS  PubMed  Google Scholar 

  4. Manes TJ, Mohiuddin Z, Bage M. Pulmonary Embolism in transit across a patent foramen ovale. Cureus. 2022;14(3):e23026. https://doi.org/10.7759/cureus.23026.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Dia A, Cifu AS, Shah AP. Management of patients with a patent foramen ovale with history of Stroke or TIA. JAMA. 2021;325(1):81–2. https://doi.org/10.1001/jama.2020.22176.

    Article  PubMed  Google Scholar 

  6. Wang X, Liu X, Zheng L, Liu Y, Guan Z, Dai J, et al. Correlation between percutaneous patent foramen ovale closure and recurrence of unexplained syncope. Front Neurol. 2023;14:1104621. https://doi.org/10.3389/fneur.2023.1104621.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Lanzone AM, Albiero R, Boldi E, Safari D, Serafin P, Lussardi G, et al. Clinical and echocardiographic outcomes after percutaneous closure of patent foramen ovale: a single center experience. Minerva Cardiol Angiol. 2023;71(2):157–64. https://doi.org/10.23736/S2724-5683.21.05609-X.

    Article  PubMed  Google Scholar 

  8. Zou R, Wang S, Wen W, Cai H, Wang Y, Liu P, et al. Risk factors and prognostic follow-up of vasovagal syncope children with seizure-like activities during head-up tilt test induced-syncope. Front Cardiovasc Med. 2022;9:916542. https://doi.org/10.3389/fcvm.2022.916542.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Mitchell C, Rahko PS, Blauwet LA, Canaday B, Finstuen JA, Foster MC, et al. Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: recommendations from the American Society of Echocardiography. J Am Soc Echocardiogr. 2019;32(1):1–64. https://doi.org/10.1016/j.echo.2018.06.004.

    Article  PubMed  Google Scholar 

  10. Kuijpers T, Spencer FA, Siemieniuk RAC, Vandvik PO, Otto CM, Lytvyn L, et al. Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic Stroke? A clinical practice guideline. BMJ. 2018;362:k2515. https://doi.org/10.1136/bmj.k2515.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Liu G, Feng Z, Feng F, Xue C, Liu F, Xie X. The correlation between patent foramen ovale and brain ischemia in plateau residents. BMC Cardiovasc Disord. 2021;21(1):381. https://doi.org/10.1186/s12872-021-02172-6.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Hara H, Virmani R, Ladich E, Mackey-Bojack S, Titus J, Reisman M, et al. Patent foramen ovale: current pathology, pathophysiology, and clinical status. J Am Coll Cardiol. 2005;46(9):1768–76. https://doi.org/10.1016/j.jacc.2005.08.038.

    Article  PubMed  Google Scholar 

  13. Berthet K, Lavergne T, Cohen A, Guize L, Bousser MG, Le Heuzey JY, et al. Significant association of atrial vulnerability with atrial septal abnormalities in young patients with ischemic Stroke of unknown cause. Stroke. 2000;31(2):398–403. https://doi.org/10.1161/01.str.31.2.398.

    Article  CAS  PubMed  Google Scholar 

  14. Li M, Jia R, Shi Y, Zhang L, Ma L, Song W, et al. Unexplained syncope highly correlated with heart patent foramen ovale. Chin J Clin Neurosci. 2016;24(3):328–31.

    Google Scholar 

  15. Horlick E, Kavinsky CJ, Amin Z, Boudoulas KD, Carroll JD, Hijazi ZM, et al. SCAI expert consensus statement on operator and institutional requirements for PFO closure for secondary prevention of paradoxical embolic Stroke: the American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Catheter Cardiovasc Interv. 2019;93(5):859–74. https://doi.org/10.1002/ccd.28111.

    Article  PubMed  Google Scholar 

  16. Kizer JR, Devereux RB. Clinical practice. Patent foramen ovale in young adults with unexplained Stroke. N Engl J Med. 2005;353(22):2361–72. https://doi.org/10.1056/NEJMcp043981.

    Article  CAS  PubMed  Google Scholar 

  17. Maher TJ, Wurtman RJ. Possible neurologic effects of Aspartame, a widely used food additive. Environ Health Perspect. 1987;75:53–7. https://doi.org/10.1289/ehp.877553.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Kjeld T, Jorgensen TS, Fornitz G, Roland J, Arendrup HC. Patent foramen ovale and atrial fibrillation as causes of cryptogenic Stroke: is treatment with Surgery superior to device closure and anticoagulation? A review of the literature. Acta Radiol Open. 2018;7(9):2058460118793922. https://doi.org/10.1177/2058460118793922.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Devendra GP, Rane AA, Krasuski RA. Provoked exercise desaturation in patent foramen ovale and impact of percutaneous closure. JACC Cardiovasc Interv. 2012;5(4):416–19. https://doi.org/10.1016/j.jcin.2012.01.011.

Download references

Acknowledgements

We thank the study participants for volunteering to participate in this study.

Funding

National High Level Hospital Clinical Research Funding (Multi-center Clinical Research Project of Peking University First Hospital) (2022CR59) and the Natural Science Foundation of Hunan Province in China (2023JJ30812) and Department of Science and Technology of Hunan Province in China (2023SK4018).

Author information

Authors and Affiliations

  1. Department of Pediatric Cardiovasology, Children’s Medical Center, The Second Xiangya Hospital, Central South University, No.139 Renmin Middle Road, Changsha, Hunan, 410011, China

    Runmei Zou, Ping Liu, Donghai Chen, Hong Cai, Yuwen Wang & Cheng Wang

  2. Department of Pediatrics, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China

    Shuo Wang

  3. Department of Pediatrics, The First Affiliated Hospital, Hunan University of Medicine, Huaihua, Hunan, 418000, China

    Jun Yan

Authors
  1. Runmei Zou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shuo Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ping Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Donghai Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jun Yan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hong Cai
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Yuwen Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Cheng Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

RZ and CW had primary responsibility for the protocol development, patient enrollment, data collecting, preliminary data analysis and writing the manuscript. SW and HC assisted with data analysis and critical revision for important content. PL, DC, JY collected the data. YW completed the head-up tilt test and transthoracic echocardiography. CW supervised the design and execution of the study, checked the data analysis, contributed to a final approval of the manuscript submitted. All authors have read and approved the final manuscript and assumed full responsibility for its contents.

Corresponding author

Correspondence to Cheng Wang.

Ethics declarations

Studies involving animals must include a statement ethics approval

No animals were involved in this study.

Ethics approval and consent to participate

The study was conducted according to the guidelines of the Declaration of Helsinki, and approved by The Second Xiangya Hospital, Central South University [Ethical Audit No. Study 012(2014)]. All participants or their responsible guardians were asked for and gave their written consent after being informed about the nature of the study.

Consent for publication

Not applicable.

Competing interests

There was no conflict of interests for this article.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zou, R., Wang, S., Liu, P. et al. The association between patent foramen ovale and unexplained syncope in pediatric patients. Ital J Pediatr 50, 2 (2024). https://doi.org/10.1186/s13052-023-01572-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13052-023-01572-y

Keywords

Italian Journal of Pediatrics

ISSN: 1824-7288

Contact us